Research map: Comparison of ultrasound visibility and retrieval success of two ultrasound-visible clips in targeted axillary dissection after neoadjuvant chemotherapy

Back to the article

Papers in this map

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) · E. A. Eisenhauer · 2008 · 30146 citations · Cited by this paper
  2. Three cases of whole breast irradiation for breast cancer in patients with Lymphangioleiomyomatosis (LAM) · 2026 · Related
  3. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial · David N. Krag · 2010 · 1949 citations · Cited by this paper
  4. Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients · 2026 · Related
  5. Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial · Robert E. Mansel · 2006 · 1690 citations · Cited by this paper
  6. BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B) · 2026 · Related
  7. Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer · Judy Caroline Boughey · 2013 · 1602 citations · Cited by this paper
  8. Fear of diagnosis as a barrier to the screening and diagnosis of breast cancer · 2026 · Related
  9. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study · Thorsten Kuehn · 2013 · 1498 citations · Cited by this paper
  10. Quality of life in women with breast cancer undergoing chemotherapy: a comparative cross-sectional study of CICC ports and PICC-ports · 2026 · Related
  11. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection · Abigail Suzanne Caudle · 2016 · 928 citations · Cited by this paper
  12. Characteristics of a multigene assay (MammaPrint/Blueprint) to predict early recurrence of hormone receptor-positive, HER2-negative breast cancer: a case‒control study (WJOG16722B) · 2026 · Related
  13. Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study · Jean-François Boileau · 2014 · 864 citations · Cited by this paper
  14. Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing · 2026 · Related
  15. Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer · Janine M. Simons · 2018 · 199 citations · Cited by this paper
  16. Breast ultrasound screening in young adult women undergoing infertility treatment at an infertility clinic: a retrospective observational study · 2026 · Related
  17. A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients · Sherko Küemmel · 2020 · 183 citations · Cited by this paper
  18. Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial · 2026 · Related
  19. Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study · Maggie Banys‐Paluchowski · 2021 · 166 citations · Cited by this paper
  20. Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy · Eleftherios P. Mamounas · 2025 · 118 citations · Cited by this paper
  21. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy · Steffi Hartmann · 2018 · 116 citations · Cited by this paper
  22. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer · Rihyeon Kim · 2019 · 108 citations · Cited by this paper
  23. Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer · Janine M. Simons · 2022 · 105 citations · Cited by this paper
  24. Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer · Sherko Küemmel · 2023 · 89 citations · Cited by this paper
  25. Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and18F-FDG PET/CT · S You · 2015 · 73 citations · Cited by this paper
  26. Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101) · William P. Weber · 2021 · 67 citations · Cited by this paper
  27. Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers · Alison Laws · 2020 · 49 citations · Cited by this paper
  28. A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection · Tienhan Sandrine Dabakuyo‐Yonli · 2009 · 48 citations · Cited by this paper
  29. Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial) · Geok Hoon Lim · 2020 · 39 citations · Cited by this paper
  30. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy · Jana de Boniface · 2022 · 34 citations · Cited by this paper
  31. Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement · Sabine Rosalie de Wild · 2024 · 34 citations · Cited by this paper
  32. Ultrasound visibility of select breast biopsy markers for targeted axillary node localization following neoadjuvant treatment: simulation using animal tissue models · Leah H. Portnow · 2020 · 26 citations · Cited by this paper
  33. Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients · C. S. Pinto · 2022 · 20 citations · Cited by this paper
  34. False Negativity of Targeted Axillary Dissection in Breast Cancer · George I. Kirkilesis · 2021 · 19 citations · Cited by this paper
  35. The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition · Takehiko Sakai · 2023 · 19 citations · Cited by this paper
  36. Clinical utility of axillary nodal markers in breast cancer · Peter A. Barry · 2023 · 18 citations · Cited by this paper
  37. Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment · Christian Sisó · 2023 · 18 citations · Cited by this paper
  38. Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – Results from the prospective AXSANA registry trial · Rosa Di Micco · 2025 · 17 citations · Cited by this paper
  39. Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection · Robert Jared Weinfurtner · 2022 · 16 citations · Cited by this paper

Source: OpenAlex (CC0)